RCT: Two vs. three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced esophageal squamous cell carcinoma.
21 Feb, 2022 | 08:25h | UTCMulticenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma – British Journal of Cancer (link to abstract – read for free here)
Commentary on Twitter
Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma
Read for free: https://t.co/vXRAP29FRo#Chemotherapy #Cancer pic.twitter.com/D7KBifTFOS
— British Journal of Cancer (@BrJCancer) February 9, 2022